About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

NCT00109083·25 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

SK Life Science, Inc.

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Established history of migraines for at least 1 year;
Have between 3 and 12 migraine attacks per month, and no more than 15 headache days in total per month;
Migraines must have first started before age 50.

You may not be if

Most frequent headache type is not migraine;
Failed 3 or more studies of effective migraine-preventing medications;
Overuse of pain medications to treat migraines;
Not willing to stop use of migraine-preventing medications;
Significant serious concomitant diseases.

The record

StatusCompleted

PhasePhase 2

Taking part300

StartedMar 2002

UpdatedAug 2, 2012

Conditions

Migraine Headaches

Where25

Northport, Alabama, United States
Phoenix, Arizona, United States
Little Rock, Arkansas, United States